Experts quoted by TODAY offer practical ways to ease one of the most common side effects people report on GLP-1 medications.
Recap by typeshit. Post by Facebook on Facebook.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A decade-old skin plumping ingredient found new demand from GLP-1 users with hollow cheeks. More than 150 companies now use it, Estée Lauder included.
Zrakovi says the extra weight affected his blood sugar and blood pressure, which led to a GLP-1 treatment story from the McLaren team.
Loading…